Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
23.8M
-
Shares change
-
-412K
-
Total reported value, excl. options
-
$277M
-
Value change
-
-$6.5M
-
Number of buys
-
48
-
Number of sells
-
-42
-
Price
-
$11.67
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2015
116 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2015.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.8M shares
of 37.4M outstanding shares and own 63.46% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (2.67M shares), DIMENSIONAL FUND ADVISORS LP (2.29M shares), NWQ INVESTMENT MANAGEMENT COMPANY, LLC (1.71M shares), Boston Partners (1.42M shares), ARIEL INVESTMENTS, LLC (1.42M shares), ROYAL BANK OF CANADA (1.26M shares), ROYCE & ASSOCIATES LLC (1.13M shares), KILLEN GROUP INC (1.02M shares), VANGUARD GROUP INC (1.02M shares), and HEARTLAND ADVISORS INC (884K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.